Clinical Trials
Search our team at AdventHealth Research Institute
Showing 1 - 9 of 9 clinical trials matching your search
-
NCT07452458
Temporally-Modulated Pulsed Radiation Therapy Versus Standard Radiation Therapy for the Treatment of Newly Diagnosed, IDH Wildtype, MGMT-Unmethylated Glioblastoma
This study is currently enrolling.Associated Conditions: RadiationResearch Area: Clinical Cancer ResearchResearch Location: Orlando -
NCT06958328
A Phase III Randomized Trial of Dose Escalated Radiation in Locally Advanced Pancreas Cancer (LAPC) Patients
This study is currently enrolling.Associated Conditions: RadiationResearch Area: Colorado Cancer ResearchResearch Location: Porter, Colorado -
A Phase III Randomized Trial of Dose Escalated Radiation in Locally Advanced Pancreas Cancer (LAPC) Patients (LAP100)
This study is currently enrolling.Associated Conditions: RadiationResearch Area: Clinical Cancer ResearchResearch Location: Orlando -
NCT04427384
A Multicenter Observational Study of GammaTile™ Surgically Targeted Radiation Therapy (STaRT) in Intracranial Brain Neoplasms
This study is currently enrolling.Associated Conditions: Neuro OncologyResearch Area: Clinical Cancer ResearchResearch Location: OrlandoThe purpose of this research is to evaluate real-world clinical outcomes and patient-reported outcomes that measure the effectiveness and safety of GammaTiles, which is the type of radiation therapy... -
NCT07166406
NRG-GI012: PHASE III RANDOMIZED TRIAL OF IO-BASED SYSTEMIC TREATMENT +/- LIVER SBRT IN HEPATOCELLULAR CANCER WITH MACROVASCULAR INVASION (HELIO-RT)
This study is currently enrolling.Associated Conditions: RadiationResearch Area: Clinical Cancer ResearchResearch Location: Orlando -
NCT07020117
NECTINIUM-2: A Phase 1b, 2-part, Multicenter, Single-arm, Open-label Study to Evaluate the Safety and Efficacy of a Nectin-4 Radiopharmaceutical ([225Ac]Ac-AKY-1189) in Patients with Previously Treated Locally Advanced or Metastatic Solid Tumors
This study is currently enrolling.Associated Conditions: RadiationResearch Area: Clinical Cancer ResearchResearch Location: OrlandoThis purpose of this research study is to test the study drugs to: See if the study drugs are safe. See if the study drugs can help treat locally advanced or metastatic urothelial carcinoma and other...
-
NCT06784752
A phase III multi-center, randomized, open-label study to evaluate the efficacy and safety of [177Lu]Lu-DOTA-TATE in patients newly diagnosed with Grade 1 and Grade 2 (Ki-67
This study is currently enrolling.Associated Conditions: RadiationResearch Area: Clinical Cancer ResearchResearch Location: OrlandoThe purpose of this study is to determine how your cancer responds to treatment with the study medication in combination with octreotide long-acting release (short ‘octreotide LAR’; the combination of...
-
NCT04892173
A Phase 3 Study of NBTXR3 Activated by Investigator's Choice of Radiotherapy Alone or Radiotherapy in Combination With Cetuximab for Platinum-based Chemotherapy-Ineligible Elderly Patients With LA-HNSCC
This study is currently enrolling.Associated Conditions: RadiationResearch Area: Clinical Cancer ResearchResearch Location: OrlandoThe purpose of this research study is to evaluate the safety and effectiveness (how well the study drug works) of JNJ-90301900 (NBTXR3) (injected directly into tumor) and used together with...
-
NCT06780670
A phase II/III, open-label, international, multi-center, randomized study of AAA817 versus standard of care in the treatment of adult participants with PSMA-positive metastatic castration-resistant prostate cancer who progressed on or after [177Lu]Lu-PSMA targeted therapy
This study is currently enrolling.Associated Conditions: RadiationResearch Area: Clinical Cancer ResearchResearch Location: OrlandoThe purpose of Phase II part of the study is to study the safety and effectiveness of the new experimental drug AAA817 at radioactivity dose of 8 MBq or at 10 MBq in patients with PSMA-positive mCRPC...
